DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Tubiana-Hulin M, Bonneterre J, Bougnoux P. et al.
Better survival with epirubicin-paclitaxel (ET) combination as first-line chemotherapy in patients with metastatic breast cancer (MBC): Final results of a phase II randomized study (abstr.).
Proc Am Soc Clin Oncol 2003; 22: 46-46
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.